InhaltsangabeEpidemiology of adenocarcinoma of the esophagogastric junction (EJ).- Clinical classification systems.- Histopathologic classification.- The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma.- Differences in the molecular biology of adenocarcinoma of the EJ.- Clinical staging.- Endoscopic mucosal resection for staging and therapy.- Surgical strategies.- Current status of sentinal lymph node biopsy in adenocarcinoma of the EJ.- Current diagnosis and future impact of micrometastases for therapeutic strategies.- Quality indicators in the surgical management of adenocarcinoma of the EJ.- Perioperative and complication management.- Multimodality therapy.- Metabolic response evaluation by PET during neoadjuvant treatment.- Molecular response prediction in multimodality treatment.

InhaltsangabeEpidemiology of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third.- Clinical Classification Systems of Adenocarcinoma of the Esophagogastric Junction.- Histopathologic Classification of Adenocarcinoma of the Esophagogastric Junction.- The Pathogenesis of Barrett's Metaplasia and the Progression to Esophageal Adenocarcinoma.- Differences in the Molecular Biology of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third.- Clinical Staging of Adenocarcinoma of the Esophagogastric Junction.- Endoscopic Mucosal Resection for Staging and Therapy of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third.- Surgical Strategies for Adenocarcinoma of the Esophagogastric Junction.- Current Status of Sentinel Lymph Node Biopsy in Adenocarcinoma of the Distal Esophagus, Gastric Cardia, and Proximal Stomach.- Current Diagnosis and Future Impact of Micrometastases for Therapeutic Strategies in Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third.- Quality Indicators of Surgery for Adenocarcinoma of the Esophagus and Gastroesophageal Junction.- Peri-Operative and Complication Management for Adenocarcinoma of the Oesophagus and Oesophagigastric Junction.- Multimodality Therapy for Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third.- Metabolic Response Evaluation by PET During Neoadjuvant Treatment for Adenocarcinoma of the Esophagus and Esophagogastric Junction.- Molecular Response Prediction in Multimodality Treatment for Adenocarcinoma of the Esophagus and Esophagogastric Junction.

Epidemiology of adenocarcinoma of the esophagogastric junction (EJ).- Clinical classification systems.- Histopathologic classification.- The pathogenesis of Barrett¿s metaplasia and the progression to esophageal adenocarcinoma.- Differences in the molecular biology of adenocarcinoma of the EJ.- Clinical staging.- Endoscopic mucosal resection for staging and therapy.- Surgical strategies.- Current status of sentinal lymph node biopsy in adenocarcinoma of the EJ.- Current diagnosis and future impact of micrometastases for therapeutic strategies.- Quality indicators in the surgical management of adenocarcinoma of the EJ.- Perioperative and complication management.- Multimodality therapy.- Metabolic response evaluation by PET during neoadjuvant treatment.- Molecular response prediction in multimodality treatment.

Hersteller:
Springer Verlag GmbH
juergen.hartmann@springer.com
Tiergartenstr. 17
DE 69121 Heidelberg